In a recent issue of the journal Diabetes Care, Peter Butler, MD, of the University of California Los Angeles weighs in on recent research showing a potential link between certain diabetes drugs and an inflammation of the cancer called pancreatitis, as well as pancreatic cancer.
Butler himself was lead researcher for a study published in the journal Gastroenterology, which reported higher rates of pancreatitis and pancreatic cancer in patients taking the ...
continue reading...